SCHEMBL16118256

SCHEMBL16118256

Cc1ccc(N=Cc2ccc(C)o2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.70
MEN1 O00255 5/20 0.70
ALDH1A1 P00352 5/20 0.70
MAPT P10636 4/20 0.70
L3MBTL1 Q9Y468 3/20 0.70
GAA P10253 3/20 0.70
MAPK1 P28482 2/20 0.70
KDM4E B2RXH2 2/20 0.70
THRB P10828 2/20 0.70
ALOX15 P16050 1/20 0.70
TSHR P16473 1/20 0.70
NPSR1 Q6W5P4 1/20 0.70
HSD17B10 Q99714 1/20 0.70
TDP1 Q9NUW8 1/20 0.70
POLB P06746 2/20 0.50
RECQL P46063 1/20 0.50
HPGD P15428 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16118373 1.00 KMT2A (0.70) KMT2AMEN1ALDH1A1MAPTL3MBTL1
SCHEMBL16101747 0.94 ALDH1A1 (0.77) KMT2AMEN1ALDH1A1MAPTL3MBTL1
SCHEMBL16101744 0.94 ALDH1A1 (0.77) KMT2AMEN1ALDH1A1MAPTL3MBTL1
SCHEMBL17367501 0.90 MAPT (0.56) KMT2AMEN1ALDH1A1MAPTL3MBTL1
SCHEMBL14571430 0.89 ALDH1A1 (0.70) KMT2AMEN1ALDH1A1MAPTL3MBTL1
SCHEMBL16118301 0.85 ALDH1A1 (0.66) KMT2AMEN1ALDH1A1MAPTL3MBTL1
SCHEMBL16118376 0.85 ALDH1A1 (0.66) KMT2AMEN1ALDH1A1MAPTL3MBTL1
SCHEMBL16095280 0.85 ALDH1A1 (0.65) KMT2AMEN1ALDH1A1MAPTL3MBTL1
SCHEMBL16095282 0.85 ALDH1A1 (0.65) KMT2AMEN1ALDH1A1MAPTL3MBTL1
SCHEMBL16118264 0.82 ALDH1A1 (0.62) KMT2AMEN1ALDH1A1MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9556137-B2 Methods for preparing alkylfurans MICROMIDAS, INC. (US) 2017-01-31 US disclosed
US-9556137-B2 Methods for preparing alkylfurans MICROMIDAS, INC. (US) 2017-01-31 US disclosed
US-20150376153-A1 METHODS FOR PREPARING ALKYLFURANS MICROMIDAS, INC. (US) 2015-12-31 US disclosed
US-20150376153-A1 METHODS FOR PREPARING ALKYLFURANS MICROMIDAS, INC. (US) 2015-12-31 US disclosed
WO-2014151100-A1 METHODS FOR PREPARING ALKYLFURANS MICROMIDAS, INC. (US) 2014-09-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150376153-A1 METHODS FOR PREPARING ALKYLFURANS ALKBH5, ALKBH2, ALKBH1 KMT2A 782/4885MEN1 1120/4885ALDH1A1 92/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.